Bluesky: @oppedahl.com Mastodon.social: @ant-like
There’s a nice opportunity to learn about PCT coming up soon in New Orleans. I will be teaching two and a half days about PCT, on April 18th through 20th. This program is sponsored by Patent Resources Group.
To find out more, or to register, click here.
There’s a great opportunity to learn about PCT, coming soon in Glendale, California.
I will be teaching a day and a half about PCT. This is part of a four-day program for IP Support Professionals. This is March 5-8, 2018. It is sponsored by Patent Resources Group.
For more information, or to register, click here.
There’s a great opportunity coming up to learn about PCT. It is a one-day program sponsored by the Schwegman firm and by WIPO. Wednesday, April 11. Yours truly will be the presenter.
It is astonishing (in a good way) that the Schwegman firm will be making this program available free of charge. If you know someone who is with the Schwegman firm, tell them “thanks”. I really mean this. Call them up or drop them an email, or thank them in person. This is really a nice thing that the Schwegman firm does for the patent community.
To find out more, or to register, click here.
How does one obtain patent protection in Montenegro through the PCT? This turns out to be a very interesting question. Continue reading “Montenegro and PCT”
https://www.uspto.gov/uspto-operating-status
Here is what the USPTO says:
While activities across much of the federal government ceased at 12:01 a.m. January 20, 2018, due to a lack of appropriated funding, the USPTO remains operational.
This is possible because the agency has access to prior year fee collections, which enables the USPTO to continue normal operations for a few weeks. Should the USPTO exhaust these funds before a government shutdown comes to an end, the agency would have to shut down at that time, although a very small staff would continue to work to accept new applications and maintain IT infrastructure, among other functions.
Further information regarding any adjustments to the USPTO’s operating status during a federal government shutdown will be posted on the USPTO website and delivered to the news media.
The Nineteenth Annual AIPLA Patent Prosecution Boot Camp will take place February 7-9 in Denver. Nowhere else will you get a faculty that includes more than three dozen extremely experienced patent practitioners, with three days of classes. For more information, or to register, click here.
Yours truly is among the presenters at this unique program.
It will be recalled (see my blog article of December 14, 2017) that most USPTO patent fees will increase, some substantially, on Tuesday, January 16, 2018. This presents an opportunity to save money. If there is some fee that you were considering paying on or after January 16, maybe you should pay it earlier, for example on Monday, January 15.
Tuesday, January 9 there will be a webinar about sequence listings. The webinar is free of charge. This webinar will be presented by two experienced practitioners, Suzannah K. Sundby and Carl Oppedahl.
As of right now, the number of people who have signed up for this webinar is less than the number of people in the world. This might mean that you have not signed up for this webinar. Which then raises the question:
Why have you not signed up for this webinar?
For more information, or to register for this free webinar about sequence listings, click here.
If you know someone who might want to attend this free webinar about sequence listings, you will probably be doing them a favor if you pass this information on to them.
If your patent application contains nucleotide or amino acid sequences, to comply with US and PCT rules you need to provide the sequences to the patent office as computer-readable sequence listings. This webinar, which is CLE accredited and is free of charge, explains how to prepare and e-file such sequence listings.
From time to time an Examiner in the USPTO recites this objection:
The abstract of the disclosure does not commence on a separate sheet in accordance with 37 CFR §§ 1.52(b)(4) and 1.72(b). A new abstract of the disclosure is required and must be presented on a separate sheet, apart from any other text.
An Examiner made such an objection a couple of days ago in one of our cases. We will be able to force the Examiner to withdraw the objection. Continue reading “Abstract is required to “commence on a separate sheet”? No!”